Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen, Inc. | -0.16% | 285.31 | 1.5% | $876.46m | |
| GILD | Gilead Sciences, Inc. | 1.70% | 89.29 | 1.0% | $695.99m | |
| MRNA | Moderna, Inc. | 2.87% | 184.15 | 0.0% | $670.48m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.59% | 768.81 | 2.6% | $502.61m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.26% | 321.59 | 1.9% | $479.07m | |
| BIIB | Biogen, Inc. | -1.26% | 288.47 | 1.8% | $402.68m | |
| ILMN | Illumina, Inc. | 0.84% | 210.28 | 3.2% | $227.84m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.73% | 104.45 | 4.2% | $163.38m | |
| BNTX | BioNTech SE | 4.90% | 170.59 | 0.0% | $158.07m | |
| AXSM | Axsome Therapeutics, Inc. | 1.09% | 79.01 | 1.6% | $148.54m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -4.15% | 1.85 | 0.7% | $129.32m | |
| RXDX | Prometheus Biosciences, Inc | 18.72% | 113.74 | 1.4% | $123.29m | |
| MRTX | Mirati Therapeutics, Inc. | -10.73% | 44.27 | 1.6% | $91.13m | |
| NVAX | Novavax, Inc. | 0.06% | 17.23 | 75.3% | $81.93m | |
| HALO | Halozyme Therapeutics, Inc. | -0.30% | 57.57 | 18.4% | $81.79m |
Company Profile
Prothena Corp. Plc is a clinical-stage neuroscience company. It focuses on the discovery and development of novel therapies to change the course of devastating diseases. The firm’s clinical pipeline includes both wholly-owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer’s disease, Parkinson’s disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.